about
Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and preventionGastrointestinal Infections in Deployed Forces in the Middle East Theater: An Historical 60 Year PerspectiveTropical and travel-associated norovirus: current conceptsHotel clinic-based diarrheal and respiratory disease surveillance in U.S. service members participating in Operation Bright Star in Egypt, 2009The extant World War 1 dysentery bacillus NCTC1: a genomic analysis.Vaccines against human diarrheal pathogens: current status and perspectivesAttenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.Intracellular activity of azithromycin against bacterial enteric pathogens.Enteric disease surveillance under the AFHSC-GEIS: current efforts, landscape analysis and vision forward.Dr. Kiyoshi Shiga: discoverer of the dysentery bacillus.The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics.Identification of a gene within a pathogenicity island of enterotoxigenic Escherichia coli H10407 required for maximal secretion of the heat-labile enterotoxin.Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adultsAncestral lineages of human enterotoxigenic Escherichia coliThe pCoo plasmid of enterotoxigenic Escherichia coli is a mosaic cointegrate.Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteersShigella isolates from the global enteric multicenter study inform vaccine development.Importance of heat-labile enterotoxin in colonization of the adult mouse small intestine by human enterotoxigenic Escherichia coli strainsDiarrhea outbreak during U.S. military training in El Salvador.Epidemiology of traveler's diarrhea.Endemic infectious diseases of Afghanistan.Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain.Antimicrobial resistance and genetic diversity of Shigella sonnei isolates from western Ireland, an area of low incidence of infectionHealthcare utilization and mortality among veterans of the Gulf War.Use of pulsed-field gel electrophoresis for comparison of similar but distinguishable isolates of Shigella sonnei collected in Ireland and ItalyMolecular characterization of the tia invasion locus from enterotoxigenic Escherichia coli.Immune response to Shigella sonnei in U.S. MarinesImmune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.In vitro activity of azithromycin against bacterial enteric pathogens.Gastrointestinal problems in modern wars: clinical features and possible mechanismsGastroenteritis outbreak in British troops, IraqIncidence, Etiology and Risk Factors for Travelers' Diarrhea during a Hospital Ship-Based Military Humanitarian Mission: Continuing Promise 2011.The burden of different pathogens in acute diarrhoeal episodes among a cohort of Egyptian children less than five years oldGenetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation.Diagnostic approach to acute diarrheal illness in a military population on training exercises in Thailand, a region of campylobacter hyperendemicity.Identification of enteroinvasive Escherichia coli and Shigella strains in pediatric patients by an IpaC-specific enzyme-linked immunosorbent assayThe EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection.Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G.
P2860
Q24530558-22AE988C-1B78-4428-AA74-30CA82F4DBE5Q26782590-D074491F-EC47-44AB-BAE7-653EE87AC6CCQ26799737-229BDC22-A0B2-46D4-B4AE-71F5AE4116F9Q30419963-FD96EDA6-34BF-4BF8-B43E-79A1C83DB8A5Q30597282-D2B57A0A-822F-4937-8A1D-D8E3CBDC2B1FQ33578045-CA6B640F-90DD-4118-AEA7-7D8F758F1D7BQ33597022-0F91BB7E-B23C-4A6D-98AB-DBBB9EC3F0CEQ33757644-B09EB914-E3F8-468A-B7F8-FA82650632F8Q33841513-1DA4B93F-0340-4CF6-92E4-485EB44D2D30Q33877398-62F6704C-30B2-4F43-B03E-4E4B57A1AA6EQ33914442-5B1C5486-DE9A-4878-AEDD-AA6343E1B73AQ34004347-FA9310F8-4DA1-411D-BDAE-7D316D7F0B68Q34007642-BBFFF798-93B0-4CDB-B277-2C135560D08CQ34046378-408BE19B-BC68-4EC1-822B-82B6DFCEAB3AQ34048353-8CB52548-B5C1-43F4-AAD5-50B3AC60AA7AQ34120919-FA12CFE4-1AD0-4279-BFE2-E3B33D052316Q34194587-0380C2B3-EFEE-4FD3-A8BD-3B559316AC99Q34202171-1B151F8A-5860-47EA-B37F-6B1524F76C21Q34334112-519372BD-2BDE-4270-9E43-134B8A576C15Q34344854-D4BA515B-73F9-43FD-AFC3-1EA795F9E448Q34464976-F1301B7E-74BA-4641-98BC-592D1EA2751AQ34645383-E273C4D3-E208-4A90-83EC-03031A8ADE71Q34716080-9D545315-5C1F-4A51-853C-247F4368330BQ34991203-5763E7E8-E1D6-424B-973E-29B5C73A6D1EQ35038311-DA5F5831-BA23-406C-A6D0-9031B7417F40Q35073470-89327F7D-00D2-458E-8090-DFDDF65ACA5EQ35499729-E1DA9F7C-1BFA-432A-BCF8-DB3C14D32ED4Q35521181-82B7C740-6BA8-4F49-94DE-CC6D31CBEAB6Q35689012-23123890-F0E0-4EDA-A0FE-D3CE2A791AFBQ35815599-799427FA-BA02-4A05-B80C-1C4B42585666Q35987020-1597B6C8-7E04-4BC8-A1B5-C0FDC813CB70Q36006695-08808E24-DA53-4529-B34E-66C1038BD3D8Q36015835-52DA9866-414F-4E0C-BE7C-4D7275AE19C3Q36167359-0CD6FCE0-43EA-4C64-A0EF-1887C91B775BQ36172686-F65019ED-FBC5-4EAE-9408-E29EC9234EAFQ36539943-9AB83361-D3BB-4FCA-AEA2-671920795CAAQ36545068-4892FFA9-5C43-4E8D-88B4-5C64C8DC6572Q36593894-879E2AC9-8524-4D97-8810-923D14198471Q36844719-492AD1BA-C2F9-424A-9DB7-F40E2583A729Q36844890-DA4E5F32-16B3-4FB6-9C76-24B19C61FD4D
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Diarrheal disease during Operation Desert Shield.
@en
Diarrheal disease during Operation Desert Shield.
@nl
type
label
Diarrheal disease during Operation Desert Shield.
@en
Diarrheal disease during Operation Desert Shield.
@nl
prefLabel
Diarrheal disease during Operation Desert Shield.
@en
Diarrheal disease during Operation Desert Shield.
@nl
P2093
P1476
Diarrheal disease during Operation Desert Shield.
@en
P2093
Bourgeois AL
Echeverria P
Escamilla J
Merrell BR
Rozmajzl P
Thornton SA
Wasserman GM
P304
P356
10.1056/NEJM199111143252006
P407
P577
1991-11-01T00:00:00Z